Live Oak Investment Partners Lumos Pharma, Inc. Transaction History
Live Oak Investment Partners
- $116 Million
- Q2 2024
A detailed history of Live Oak Investment Partners transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Live Oak Investment Partners holds 11 shares of LUMO stock, worth $41. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$41
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LUMO
# of Institutions
41Shares Held
2.19MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA415KShares$1.58 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$1.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$929,9520.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$822,2510.0% of portfolio
-
Acuitas Investments, LLC141KShares$538,8670.19% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $32M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...